Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions

John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company , urged that biopharmaceuticals be included in transatlantic trade and economic discussions.